PTGX: Protagonist Therapeutics Inc Sotuvga nisbatan narx
Protagonist Therapeutics qon va gastrointestinal buzilishlar uchun inyeksiyalarni almashtiruvchi innovatsion oral terapiyalarni ishlab chiqadi. Ushbu narx-savdo ko'rsatkichi grafigi joriy tendentsiyalarni aks ettiradi, bunda qiymat 15.90 atrofida saqlanmoqda. Sintez qilingan patentlardan olinadigan yuqori marjalar masshtab iqtisodiyotini ta'minlaydi. Biznes istiqbollari rusfertide muvaffaqiyatiga va royalti daromadlarini generatsiya qilish uchun yirik hamkorlar bilan strategik hamkorlikka bog'liq.
Protagonist Therapeutics Inc (PTGX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Protagonist Therapeutics|PTGX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Protagonist Corp|PTGX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Protagonist Therapeutics Inc|PTGX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarzdorlik Protagonist Therapeutics|Shoshilinch likvidlik protagonist-inc.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
PTGX - Kompaniyaning sof foydasi|Sof foyda prognozi Protagonist Therapeutics|PTGX - P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Protagonist Therapeutics, Inc.|PTGX - Narxning foydaga va o‘sish sur’atiga nisbati|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Protagonist Therapeutics Inc|PTGX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda Protagonist Therapeutics|PTGX - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi protagonist-inc.com|PTGX - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi Protagonist Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:PTGX protagonist-inc.com
P/S koeffitsiyenti biznesning bozor qiymatini uning savdo hajmi bilan nisbatda aks ettiradi, bu esa investorlarga inflyatsiyaviy bosimlar sharoitida aktiv uchun qanchalik ortiqcha to'lov qilinganini aniqlash imkonini beradi. GURU.Markets platformasida savdo hajmidagi narxni tahlil qilishda, Protagonist Therapeutics (PTGX) kompaniyasining qimmatbaho sovuq zanjirli peptid logistikasiga sarflayotgan xarajatlari marjalarga ta'sir qilishini va ushbu ko'rsatkich kapitalizatsiya samaradorligini monitoring qilish uchun kalit hisoblanishini hisobga olish muhimdir.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Narxning sotuvga nisbati IMVT|Kiniksa Pharmaceuticals (KNSA) - Narxning daromadga nisbati|grifols.com - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Adaptive Biotechnologies Corporation|Sotuvga nisbatan narx Celldex Therapeutics Inc CLDX|Kapitalizatsiyaning daromadga nisbati AUPH (Aurinia Pharma)|Kapitalizatsiyaning sotish hajmiga nisbati BCRX|P/S multiplikatori VERA (Vera Therapeutics, Inc.)|P/S multiplikatori dianthustx.com DNTH|Pharvaris - P/S multiplikatori|Narx/daromad multiplikatori AbCellera Biologics Inc. (ABCL)|Tourmaline Corp (TRML) - Narxning daromadga nisbati|Sotuvga nisbatan narx Precigen Corp (PGEN)|Narxning daromadga nisbati Pharming Group N.V.|Kapitalizatsiya va daromad nisbati NKTR (nektar.com)|P/S multiplikatori UPB|Narx/daromad koeffitsiyenti Zenas Bio|Narxning daromadga nisbati Immunome Corp IMNM|Narx/daromad koeffitsiyenti Gossamer Bio Corp. (GOSS)|KALV: Kapitalizatsiyaning daromadga nisbati|septerna.com - Kapitalizatsiyaning sotish hajmiga nisbati|PVLA (Pieris Pharmaceuticals, Inc.) - Kapitalizatsiyaning daromadga nisbati|Savara Inc - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati RIGL|ANAB (AnaptysBio Inc.) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori ATXS|ENGN (engene.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori RAPT (RAPT Therapeutics)|Aerovate Therapeutics, Inc. (JBIO) - Sotuvga nisbatan narx|ACRS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati KYTX (Kyverna Therapeutics, Inc)|TLSA: P/S multiplikatori|cabalettabio.com (CABA) - P/S multiplikatori|Narxning daromadga nisbati Ventyx Biosciences, Inc.|Theratechnologies, Inc. - Narxning sotuvga nisbati|P/S multiplikatori AVTX|ELDN - Sotuvga nisbatan narx|Agenus - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori climbbio.com CLYM|ZURA: Kapitalizatsiyaning daromadga nisbati|aTyr Pharma Inc - Kapitalizatsiyaning sotish hajmiga nisbati|ADAG: P/S multiplikatori|IMA - Narx/daromad koeffitsiyenti|STTK (Shattuck Labs Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Equillium Bio (EQ)|Narxning daromadga nisbati Connect Biopharma (CNTB)|Narx/daromad koeffitsiyenti immunic-therapeutics.com|Narxning daromadga nisbati Atara Bio ATRA|IFRX (InflaRx NV) - Narxning sotuvga nisbati|XFOR: Kapitalizatsiyaning daromadga nisbati|Adicet Bio - Kapitalizatsiyaning sotish hajmiga nisbati|CELU: P/S multiplikatori|Narx/daromad multiplikatori INmune Bio Inc INMB|Kapitalizatsiyaning daromadga nisbati BRNS|Kapitalizatsiya va daromad nisbati KZR (Kezar Life Sciences Inc)|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|AKTX: Narxning sotuvga nisbati|P/S multiplikatori ENLV (Enlivex Therapeutics Ltd.)|Bozor kapitallashuvining daromadga nisbati QTTB|GeoVax Labs Inc - P/S multiplikatori|EDSA - P/S multiplikatori|iBio, Inc. (IBIO) - Narxning daromadga nisbati|Carisma Therapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiyaning daromadga nisbati Bolt Bio (BOLT)|P/S multiplikatori HCWB|P/S multiplikatori aptevotherapeutics.com (APVO)|AIM ImmunoTech Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ADTX|GRI Bio - P/S multiplikatori|Narx/daromad koeffitsiyenti XORTX Therapeutics Inc XRTX|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Revelation Biosciences Corp|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiyaning daromadga nisbati scinai.com (SCNI)|Kapitalizatsiyaning daromadga nisbati CALI (CalciMedica, Inc.)|P/S multiplikatori affimed.com (AFMD)|Narxning daromadga nisbati Allakos ALLK|HOOK: Kapitalizatsiya va daromad nisbati|IGM Bio - P/S multiplikatori|Sotuvga nisbatan narx iteostherapeutics.com|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Narxning sotuvga nisbati TCBP (TC BioPharm (Holdings) Plc)|Narxning daromadga nisbati Third Harmonic Bio, Inc
